Home › GSK in $350 million deal to develop cancer drugs with UK biotech firm - FT
 

Keywords :   


GSK in $350 million deal to develop cancer drugs with UK biotech firm - FT

2014-06-02 06:25:29| Biotech - Topix.net

GlaxoSmithKline Plc has agreed a deal worth more than $350 million with UK biotech company Adaptimmune to develop cancer drugs, the Financial Times reported on Monday.

Tags: million deal firm develop

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.09Hurricane John Graphics
23.09Hurricane John Forecast Discussion Number 5
23.09Hurricane John Wind Speed Probabilities Number 5
23.09Eastern North Pacific Tropical Weather Outlook
23.09Hurricane John Forecast Advisory Number 5
23.09Hurricane John Public Advisory Number 5
23.09Potential Tropical Cyclone Nine Public Advisory Number 1A
23.09Summary for Potential Tropical Cyclone Nine (AT4/AL092024)
More »